CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $972,397 | +4.9% | 578,808 | +76.8% | 0.00% | – |
| Q2 2023 | $926,599 | -43.8% | 327,420 | -2.5% | 0.00% | -100.0% |
| Q1 2023 | $1,649,132 | -54.5% | 335,872 | -0.4% | 0.00% | 0.0% |
| Q4 2022 | $3,620,561 | +18.8% | 337,110 | +3.5% | 0.00% | 0.0% |
| Q3 2022 | $3,048,000 | +10.1% | 325,585 | +7.4% | 0.00% | 0.0% |
| Q2 2022 | $2,769,000 | -26.7% | 303,171 | -2.4% | 0.00% | 0.0% |
| Q1 2022 | $3,776,000 | -16.8% | 310,718 | -16.6% | 0.00% | 0.0% |
| Q4 2021 | $4,537,000 | -19.4% | 372,481 | +2.2% | 0.00% | -50.0% |
| Q3 2021 | $5,632,000 | +10.8% | 364,493 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $5,084,000 | -32.0% | 356,224 | +3.5% | 0.00% | -33.3% |
| Q1 2021 | $7,472,000 | +76.5% | 344,146 | +23.0% | 0.00% | +50.0% |
| Q4 2020 | $4,233,000 | +19.5% | 279,758 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $3,543,000 | -25.9% | 278,381 | -0.4% | 0.00% | 0.0% |
| Q2 2020 | $4,781,000 | +37.1% | 279,590 | +5.9% | 0.00% | 0.0% |
| Q1 2020 | $3,487,000 | -14.9% | 263,953 | +3.8% | 0.00% | 0.0% |
| Q4 2019 | $4,097,000 | -9.8% | 254,279 | +2.3% | 0.00% | -33.3% |
| Q3 2019 | $4,544,000 | +8.0% | 248,566 | +27.0% | 0.00% | 0.0% |
| Q2 2019 | $4,208,000 | +12.9% | 195,685 | +3.0% | 0.00% | +50.0% |
| Q1 2019 | $3,728,000 | +56.1% | 189,968 | +3.4% | 0.00% | 0.0% |
| Q4 2018 | $2,388,000 | -45.1% | 183,681 | +1.1% | 0.00% | -33.3% |
| Q3 2018 | $4,351,000 | +282.7% | 181,655 | +206.2% | 0.00% | +200.0% |
| Q2 2018 | $1,137,000 | +68.9% | 59,335 | +9.2% | 0.00% | 0.0% |
| Q1 2018 | $673,000 | +1.1% | 54,335 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $666,000 | +24.3% | 54,335 | +38.9% | 0.00% | – |
| Q3 2017 | $536,000 | -11.1% | 39,117 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $603,000 | -17.3% | 39,117 | -1.3% | 0.00% | 0.0% |
| Q1 2017 | $729,000 | +183.7% | 39,617 | +43.5% | 0.00% | – |
| Q4 2016 | $257,000 | +11.3% | 27,617 | 0.0% | 0.00% | – |
| Q3 2016 | $231,000 | +73.7% | 27,617 | 0.0% | 0.00% | – |
| Q2 2016 | $133,000 | -22.7% | 27,617 | 0.0% | 0.00% | – |
| Q1 2016 | $172,000 | -63.1% | 27,617 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $466,000 | +18.0% | 27,617 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $395,000 | +64.6% | 27,617 | +40.1% | 0.00% | – |
| Q2 2015 | $240,000 | +11.6% | 19,717 | +56.1% | 0.00% | – |
| Q2 2014 | $215,000 | – | 12,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |